Source:http://linkedlifedata.com/resource/pubmed/id/20601178
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2010-8-23
|
pubmed:abstractText |
Licochalcone, a constituent of licorice, has antitumor, antimicrobial, and anti-inflammatory effects. Recently, licochalcone E was isolated from the roots of Glycyrrhiza inflata and its biological functions are not fully examined. In this study, we investigated its ability to modulate production of IL-12p40, a common subunit of IL-12 and IL-23. Licochalcone E dose-dependently inhibited IL-12p40 production from lipopolysaccharide-stimulated RAW264.7 macrophage cells. The repressive effect was mapped to a region in the IL-12 gene promoter containing a binding site for NF-kappaB. Furthermore, licochalcone E decreased binding to the NF-kappaB site in RAW264.7 macrophage cells. Using a chronic allergic contact dermatitis model induced by repeated application of oxazolone, we showed that licochalcone E inhibited the increased IL-12p40 expression and ear thickness induced by oxazolone. Taken together, licochalcone E inhibits IL-12p40 production and has therapeutic potential to reduce skin inflammation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Chalcones,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-12 Subunit p40,
http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B,
http://linkedlifedata.com/resource/pubmed/chemical/Oxazolone,
http://linkedlifedata.com/resource/pubmed/chemical/licochalcone E
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1878-1705
|
pubmed:author | |
pubmed:copyrightInfo |
(c) 2010 Elsevier B.V. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1119-26
|
pubmed:meshHeading |
pubmed-meshheading:20601178-Animals,
pubmed-meshheading:20601178-Anti-Inflammatory Agents,
pubmed-meshheading:20601178-Cells, Cultured,
pubmed-meshheading:20601178-Chalcones,
pubmed-meshheading:20601178-Chronic Disease,
pubmed-meshheading:20601178-Dermatitis, Allergic Contact,
pubmed-meshheading:20601178-Down-Regulation,
pubmed-meshheading:20601178-Female,
pubmed-meshheading:20601178-Interleukin-12 Subunit p40,
pubmed-meshheading:20601178-Macrophages,
pubmed-meshheading:20601178-Mice,
pubmed-meshheading:20601178-Mice, Inbred C57BL,
pubmed-meshheading:20601178-NF-kappa B,
pubmed-meshheading:20601178-Oxazolone,
pubmed-meshheading:20601178-Promoter Regions, Genetic
|
pubmed:year |
2010
|
pubmed:articleTitle |
Licochalcone E reduces chronic allergic contact dermatitis and inhibits IL-12p40 production through down-regulation of NF-kappa B.
|
pubmed:affiliation |
College of Pharmacy and Research Institute of Drug Development, Chonnam National University, Gwangju 500-757, Republic of Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|